Aleve and Paranasal sinus hypersecretion - a phase IV clinical study of FDA data

Summary:

Paranasal sinus hypersecretion is found among people who take Aleve, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Aleve and have Paranasal sinus hypersecretion. It is created by eHealthMe based on reports of 61,515 people who have side effects when taking Aleve from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 01, 2022

61,515 people reported to have side effects when taking Aleve.
Among them, 11 people (0.02%) have Paranasal sinus hypersecretion.


What is Aleve?

Aleve has active ingredients of naproxen sodium. It is often used in pain. eHealthMe is studying from 63,511 Aleve users for its effectiveness, alternative drugs and more.

What is Paranasal sinus hypersecretion?

Paranasal sinus hypersecretion is found to be associated with 652 drugs and 373 conditions by eHealthMe.

Number of Aleve and Paranasal sinus hypersecretion reports submitted per year:

Could Aleve cause Paranasal sinus hypersecretion?

Gender of people who have Paranasal sinus hypersecretion when taking Aleve *:

  • female: 63.64 %
  • male: 36.36 %

Age of people who have Paranasal sinus hypersecretion when taking Aleve *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 10 %
  • 50-59: 30 %
  • 60+: 60 %

Common drugs people take besides Aleve *:

  1. Humira: 4 people, 36.36%
  2. Zometa: 1 person, 9.09%
  3. Zetia: 1 person, 9.09%
  4. Losartan: 1 person, 9.09%
  5. Lortab: 1 person, 9.09%
  6. Lipitor: 1 person, 9.09%
  7. Latuda: 1 person, 9.09%
  8. Lasix: 1 person, 9.09%
  9. Insulin: 1 person, 9.09%
  10. Humalog: 1 person, 9.09%

Common side effects people have besides Paranasal sinus hypersecretion *:

  1. Fatigue (feeling of tiredness): 6 people, 54.55%
  2. Cough: 5 people, 45.45%
  3. Neck Pain: 4 people, 36.36%
  4. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 4 people, 36.36%
  5. Joint Range Of Motion Decreased (disease of joint movement): 4 people, 36.36%
  6. Joint Pain: 4 people, 36.36%
  7. Back Pain: 4 people, 36.36%
  8. Renal Disorder (kidney disease): 3 people, 27.27%
  9. Nausea (feeling of having an urge to vomit): 3 people, 27.27%
  10. Dysstasia (difficulty in standing): 3 people, 27.27%

Common conditions people have *:

  1. Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 27.27%
  2. Stress And Anxiety: 2 people, 18.18%
  3. Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 18.18%
  4. Irritable Bowel Syndrome: 1 person, 9.09%
  5. Arrhythmias (irregular heartbeat): 1 person, 9.09%
  6. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 9.09%
  7. Depression: 1 person, 9.09%
  8. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 9.09%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
  10. High Blood Cholesterol: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Aleve and have Paranasal sinus hypersecretion?

Check whether Paranasal sinus hypersecretion is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Aleve:

Paranasal sinus hypersecretion treatments and more:

COVID vaccines that are related to Paranasal sinus hypersecretion:

How severe was Paranasal sinus hypersecretion and when was it recovered:

Expand to all the drugs that have ingredients of naproxen sodium:

Common drugs associated with Paranasal sinus hypersecretion:

All the drugs that are associated with Paranasal sinus hypersecretion:

Common conditions associated with Paranasal sinus hypersecretion:

All the conditions that are associated with Paranasal sinus hypersecretion:

How the study uses the data?

The study uses data from the FDA. It is based on naproxen sodium (the active ingredients of Aleve) and Aleve (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: